Sanofi (Hangzhou) Phase I 0.22MWp Photovoltaic Power Generation Project

Congratulations to Sanofi (Hangzhou) Phase I 0.22MWp photovoltaic power generation project has been connected to the grid on September 9, 2024 !

The project has an installed capacity of 0.22MWp and generates an average of 211,000 KWh of electricity per year, which can reduce the average annual carbon emissions by 69.72 tons. The project adopts FM certified cement roof photovoltaic system, actively practicing the concept of green development in the pharmaceutical industry, providing clean electricity for pharmaceutical production, reducing carbon emissions in the production process, and helping the pharmaceutical industry to realize sustainable development.

Our company is responsible for the construction of the project, and in the construction process, whether it is infrastructure construction, equipment installation or line laying, we strictly follow the highest standards of the industry to ensure the high quality of the project. At the same time, we rationalized the construction process and efficiently deployed manpower and equipment resources, which greatly improved the efficiency of the project. We are grateful for Sanofi (Hangzhou)'s trust and support and look forward to cooperating again!

Sanofi (Hangzhou) Pharmaceutical Co., Ltd. is a foreign joint venture limited liability company focusing on pharmaceutical manufacturing. As part of the Sanofi Group, the company adheres to Sanofi's philosophy as a leading global pharmaceutical and healthcare company, and is committed to researching, developing, and promoting innovative therapeutic solutions based on patient needs. With abundant intellectual property rights and administrative licenses, the company actively participates in bidding programs and has deep accumulation and experience in the pharmaceutical manufacturing field.